Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review()

BACKGROUND: The clinical outcomes following rituximab (RTX) treatment in patients with systemic lupus erythematosus (SLE) is highly variable. We aimed to identify predictive and prognostic factors associated with RTX therapy outcomes in patients with SLE. METHODS: Studies in adults and paediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirone, Carmelo, Mendoza-Pinto, Claudia, van der Windt, Daniëlle A., Parker, Ben, O׳Sullivan, Miriam, Bruce, Ian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695978/
https://www.ncbi.nlm.nih.gov/pubmed/28602359
http://dx.doi.org/10.1016/j.semarthrit.2017.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695978/
https://www.ncbi.nlm.nih.gov/pubmed/28602359
http://dx.doi.org/10.1016/j.semarthrit.2017.04.010

Ejemplares similares